ArticleISRN oncology2014

The human epidermal growth factor receptor 2 screening tests for breast cancer suggested by the new updated recommendation of the american society of clinical oncology/college of american pathologists will involve a rise of the in-situ hybridization tests for the European laboratories of pathology.

Christian Garbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.